American Heart Journal
Volume 157, Issue 5 , Pages 805-810.e2 , May 2009

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

  • Michael D. Ezekowitz, MBChB, DPhil

      Affiliations

    • Lankenau Institute for Medical Research and The Heart Center, Wynnewood, PA
    • Corresponding Author InformationReprint requests: Michael D. Ezekowitz, MD, PhD, Lankenau Institute for Medical Research and The Heart Center, Wynnewood.
    • ,
  • Stuart Connolly, MD

      Affiliations

    • Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Amit Parekh, MD

      Affiliations

    • Lankenau Institute for Medical Research and The Heart Center, Wynnewood, PA
    • ,
  • Paul A. Reilly, PhD

      Affiliations

    • Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT
    • ,
  • Jeanne Varrone, MD

      Affiliations

    • Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT
    • ,
  • Susan Wang, PhD

      Affiliations

    • Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT
    • ,
  • Jonas Oldgren, MD, PhD

      Affiliations

    • Uppsala Clinical Research Centre, Uppsala, Sweden
    • ,
  • Ellison Themeles

      Affiliations

    • Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Lars Wallentin, MD, PhD

      Affiliations

    • Uppsala Clinical Research Centre, Uppsala, Sweden
    • ,
  • Salim Yusuf, FRCP(c), FRSC, DPhil

      Affiliations

    • Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada

Received 24 November 2008 ,Accepted 5 February 2009.

 Registered clinical trial #: NCT00262600.

PII: S0002-8703(09)00129-X

doi: 10.1016/j.ahj.2009.02.005

American Heart Journal
Volume 157, Issue 5 , Pages 805-810.e2 , May 2009

Article Tools

* Image Usage & Resolution